Diabetes Care 31:1123-1125, 2008 DOI: 10.2337/dc07-2195 © 2008 by the American Diabetes Association
Role of Adiponectin in Matching of Fetal and Placental Weight in Mothers With Type 1 DiabetesFrom the Faculty of Medicine, University of Glasgow, Glasgow, U.K Corresponding author: Dr. Scott Nelson, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, U.K. G31 2ER. E-mail: s.nelson{at}clinmed.gla.ac.uk OBJECTIVE—To assess the association of fetal hormones with placental growth and fetal weight–to–placental weight ratio index (FPI) in pregnancies complicated by maternal diabetes. RESEARCH DESIGN AND METHODS—We conducted a prospective study using umbilical venous blood samples taken at birth from 122 offspring of mothers with type 1 diabetes (OT1D) and 46 control subjects. RESULTS—Placental weight (P = 0.009) and gestation-adjusted birth weight (P < 0.001) were increased in OT1D, but FPI was unaltered (P = 0.33). Placental weight correlated with birth weight (P < 0.001) and cord leptin (P < 0.001) in control subjects and OT1D, with further relationships with cord insulin, IGF-1, IGF-binding protein-3 (IGFBP-3), and triceps and subscapular thickness in OT1D. FPI was associated with adiponectin in both groups, even after adjustment for confounders. CONCLUSIONS—Placental and fetal growth show a parallel increase in mothers with type 1 diabetes. The possible role of adiponectin in matching of fetal and placental growth merits further study.
Abbreviations: CRP, C-reactive protein CTV, contribution to variance FPI, fetal weight–to–placental weight ratio index IGFBP-3, IGF-binding protein-3 OT1D, offspring of mothers with type 1 diabetes
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||